{"anticipatedPostingDate":"2027-11","denomUnitsSelected":"Participants","description":"To assess the palatability of the selumetinib granule formulation","reportingStatus":"NOT_POSTED","timeFrame":"Twice daily (morning and evening), from the first day of study treatment (Cycle 1 Day 1) for one week, from Cycle 7 Day 1 for one week (each cycle is 28 days)","title":"Palatability Using the Parent-reported Observer Palatability Questionnaire","type":"SECONDARY"}